Rapigen, Inc.

⭐️ We are continually challenging ourselves to become a leading company specialized in in-vitro diagnostics and dedicated to creating value for human health innovation. Rapigen Inc. was the first to successfully commercialize rapid diagnostics using Black Gold Nanoparticles and a dual-color system. We have leveraged this innovation through successful collaborations with various international organizations, including the WHO, Bill & Melinda Gates Foundation, Global Fund, PATH, and FIND, on numerous impactful projects. We now offer around 70 products for human and veterinary use, exporting to over 52 countries worldwide. Since 2023, we have confidently expanded into the molecular diagnostics field, manufacturing and supplying a wide range of PCR reagents and developing diagnostic kits for various infectious diseases. We understand the importance of promoting healthier lives, which is why in addition to diagnostics, we are committed to providing health screening centers and food-related solutions.